Assignee
SCHEINBERG DAVID A
US·13 granted patents·6 pending applications·101 citations·filing 2005–2023
Top patents by PatentIndex Score
19 records- 0195US9074000B2T cell receptor-like antibodies specific for a WT1 peptide presented by HLA-A2SCHEINBERG DAVID A·Filed 2012·Granted Jul 7, 2015·39 cites·32 claims
- 0293US8765687B2WT1 HLA class II-binding peptides and compositions and methods comprising sameSCHEINBERG DAVID A·Filed 2006·Granted Jul 1, 2014·28 cites·20 claims
- 0391US9265816B2Immunogenic WT-1 peptides and methods of use thereofSCHEINBERG DAVID A·Filed 2007·Granted Feb 23, 2016·16 cites·12 claims
- 0483US8540965B2Single wall nanotube constructs and uses thereforSCHEINBERG DAVID A·Filed 2006·Granted Sep 24, 2013·8 cites·6 claims
- 0581US9629927B2Single wall nanotube constructs and uses thereofSCHEINBERG DAVID A·Filed 2013·Granted Apr 25, 2017·4 cites·6 claims
- 0679US10900037B2Targeted self-assembly of functionalized carbon nanotubes on tumorsSCHEINBERG DAVID A·Filed 2018·Granted Jan 26, 2021·1 cites·7 claims
- 0777US9976137B2Targeted self-assembly of functionalized carbon nanotubes on tumorsSCHEINBERG DAVID A·Filed 2014·Granted May 22, 2018·4 cites·8 claims
- 0871US9289519B2Alpha emitting constructs and uses thereofSCHEINBERG DAVID A·Filed 2013·Granted Mar 22, 2016·1 cites·5 claims
- 0968US2023364276A1One-Step Labeling of Antibodies to High Specific Activity with Actinium-225SCHEINBERG DAVID A·Filed 2023·Application pending·0 cites
- 1066US11564988B2Single wall nanotube constructs and uses thereofSCHEINBERG DAVID A·Filed 2019·Granted Jan 31, 2023·0 cites·6 claims
- 1164US10406236B2Single wall nanotube constructs and uses thereofSCHEINBERG DAVID A·Filed 2017·Granted Sep 10, 2019·0 cites·5 claims
- 1263US2010239547A1Synthetic hla binding peptide analogues and uses thereofSCHEINBERG DAVID A·Filed 2009·Application pending·0 cites
- 1363US2021230592A1Targeted Self-Assembly of Functionalized Carbon Nanotubes on TumorsSCHEINBERG DAVID A·Filed 2021·Application pending·0 cites
- 1453US11660357B2One-step labeling of antibodies to high specific activity with actinium-225SCHEINBERG DAVID A·Filed 2015·Granted May 30, 2023·0 cites·9 claims
- 1553US8486409B2Alpha-emitting constructs and uses thereofSCHEINBERG DAVID A·Filed 2010·Granted Jul 16, 2013·0 cites·12 claims
- 1651US2006153861A1BCR-ABL imatinib resistance-associated peptides and methods of use thereofSCHEINBERG DAVID A·Filed 2005·Application pending·0 cites
- 1749US9045756B2Compositions and methods for treating cancer and other diseasesSCHEINBERG DAVID A·Filed 2010·Granted Jun 2, 2015·0 cites·17 claims
- 1842US2006134129A1Synthetic HLA binding peptide analogues and uses thereofSCHEINBERG DAVID A·Filed 2005·Application pending·0 cites
- 1942US2006127409A1Bcr-abl vaccines and methods of use thereofSCHEINBERG DAVID A·Filed 2005·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →